1. Introduction {#sec1}
===============

*Meta*-cresol (*m*-cresol, 3-methylphenol) is an important specialty chemical and platform compound. *m*-Cresol and 4-chloro-*m*-cresol are utilized as disinfectants and antiseptic agents because of their antibacterial and antifungal properties ([@bib22]; [@bib25]; [@bib27]; [@bib35]). Cresols also act as antioxidants scavenging reactive oxygen species ([@bib44]). As platform compound *m*-cresol is suitable for synthesis of several chemicals with high market value. The most prominent industrial example is menthol, which is chemically synthesized via alkylation of *m*-cresol to thymol and further hydrogenation to menthol ([@bib43]). Because of its peppermint odor, L-menthol is a desired flavor in chewing gum and toothpaste ([@bib4]).

Currently, *m*-cresol is mainly produced by chemical processes from fossil resources, and additional purification steps have to be applied to isolate it from *o*-, *m*-, *p*-cresol mixtures. Due to limitations in fossil resource reserves and environmental concerns, chemical synthesis of *m*-cresol is not sustainable and biotechnological production from renewable resources desirable. Many *Penicillium* and *Aspergillus* species can natively synthesize *m*-cresol as an intermediate in biosynthesis of the mycotoxin patulin ([@bib29]).

The first steps of patulin biosynthesis are catalyzed by the iterative polyketide synthase (PKS) 6-methylsalicylic acid synthase (MSAS) and the 6-methylsalicylic acid (6-MSA) decarboxylase leading to formation of *m*-cresol ([@bib29]). MSAS contains different functional domains such as ketosynthase (KS), acyltransferase (AT), thioester hydrolase (TH), ketoreductase (KR), and acyl carrier protein (ACP) ([@bib28]) on 180 kDa homotetramer subunits ([@bib34]) and catalyzes chain elongation and modification in an iterative fashion ([Fig. 1](#fig1){ref-type="fig"}). This PKS utilizes one acetyl-CoA and three malonyl-CoA in three decarboxylative claisen thioester condensations and one TH-mediated hydrolysis after the third elongation round to form 6-methylsalicylic acid (6-MSA) ([@bib28]).Fig. 1Metabolic pathway for *m*-cresol production in *S. cerevisiae* via 6-methylsalicylic acid (6-MSA) synthesis. The 6-methylsalicylic acid synthase (MSAS) consists of multiple domains: the ketoacylsynthase (KS), acyltransferase (AT), thioester hydrolase (TH), ketoreductase (KR), and acyl carrier protein (ACP). MSAS must be activated by phosphopantetheinylation, and catalyzes the synthesis of 6-MSA from one acetyl-CoA and three malonyl-CoA under consumption of one NADPH. 6-MSA decarboxylase can further convert 6-MSA to *m*-cresol, valuable for the flavor and pharmaceutical industry. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 1

Because of their anticancer, antibiotic, mycotoxic or cholesterol-lowering properties of polyketides including polyphenols, macrolides, polyenes, enediynes and polyethers ([@bib17]), interest for high-level production of polyketides has increased. Due to difficult cultivations and genetical limitations of their native fungal hosts, heterologous production systems are promising alternatives. The *MSAS* gene of *Penicillium patulum* was already heterologously expressed in *Streptomyces coelicolor*, *Escherichia coli* and *Saccharomyces cerevisiae* for 6-MSA production ([@bib3]; [@bib19]; [@bib38]). In *E. coli* and *S. cerevisiae* co-expression of a suitable phosphopantetheinyl transferase (PPT), for example *sfp* from *Bacillus subtilis* or *npgA* from *Aspergillus nidulans*, was required for an active *holo*-form of the ACP domain of MSAS ([@bib19]; [@bib38]). High-level expression together with engineering of the endogenous metabolism and precursor supply resulted in 6-MSA titers up to 67 mg/L in *S. coelicolor* ([@bib3]), 75 mg/L in *E. coli*, 554 mg/L in *S. cerevisiae* in minimal medium ([@bib39]) and 1.7 g/L in *S. cerevisiae* in YPD ([@bib19]). Besides MSAS, also the 6-MSA decarboxylase *patG* from *Aspergillus clavatus* has already been expressed in *S. cerevisiae* but was used only in biotransformation assays after supplementation of the medium with 6-MSA ([@bib33]). *S. cerevisiae* as a heterologous host for biotechnological production processes has several advantages compared to other microorganisms. It is quite robust in harsh industrial fermentation conditions, not sensitive against phages, able to ferment sugars at low pH, and many genetic tools are available for genetic engineering ([@bib12]; [@bib24]; [@bib40]).

In this study, we established the pathway for *de novo* production of *m*-cresol from glucose in *S. cerevisiae*. First, we compared different MSAS variants and PPT for production of the intermediate 6-MSA in *S. cerevisiae*. We established functional expression of *patG* from *A. clavatus* in biotransformation assays with 6-MSA and evaluated the toxic effect of the product *m*-cresol on yeast. Finally, combining the heterologous expression of the most promising variants of *MSAS, PPT* and *patG* from multi-copy plasmids together with genomic integration of the expression constructs enabled *de novo* production of *m*-cresol from glucose in complex medium in yeast up to toxic levels.

2. Material and methods {#sec2}
=======================

2.1. Strains and plasmids {#sec2.1}
-------------------------

Yeast strains and plasmids used in this study are listed in [Table 1](#tbl1){ref-type="table"}. Yeast strains from freshly streaked YPD (= complex medium with glucose) plates (20 g/L peptone, 10 g/L yeast extract, 20 g/L glucose) were used for cultivations. SCD medium consisted of 1.7 g/L yeast nitrogen base without amino acids, 5 g/L ammonium sulfate and 20 g/L glucose. *E. coli* DH10β (Gibco BRL, Gaithersburg, MD) was utilized for subcloning of plasmids and grown in lysogeny broth (LB)-medium (10 g/L trypton, 5 g/L yeast extract, 5 g/L sodium chloride, pH 7.5). For plasmid maintenance appropriate antibiotics (200 mg/L hygromycin, 200 mg/L G418, 100 mg/L ampicillin) were added to media.Table 1Plasmids and yeast strains used in the present study. Genes from *Saccharomyces cerevisiae* (Sc), *Penicillium patulum* (Pp), *Aspergillus nidulans* (An), *Aspergillus niger* (Ani) *Aspergillus clavatus* (Ac), codon-optimized genes (opt) or variants previously used by [@bib39] (var) are indicated by prefixes in superscript. Other abbreviations: *hphNT1*: hygromycin resistance; *Amp*^r^: ampicillin resistance; *kanMX*: kanamycin resistance. If not stated otherwise, promoters (p) were taken 1--500 bp upstream and terminators (t) 1--300 bp downstream of respective open reading frames.Table 1PlasmidPlasmid based onRelevant featuresReferencepRS42K--*2μ, kanMX, Amp*^*r*^[@bib37]pRS62H--*2μ, hphNT1, Amp*^*r*^*, HXT7p*^*−1-\ −392*^*, FBA1t*[@bib9]pJHV1pRS42K*2μ, kanMX, Amp*^*r*^*, MET25p*^*−1-\ −384*^*, CYC1t*This workpJHV2pRS62H*2μ, hphNT1, Amp*^*r*^*, HXT7p*^*−1\ -−392*^*-*^*Anopt*^*npgA-FBA1t*This workpJHV5pJHV7*2μ, kanMX, Amp*^*r*^*, PGK1p-*^*Ani*^*MSAS-CYC1t*This workpJHV7pRS42K*2μ, kanMX, Amp*^*r*^*, PGK1p, CYC1t*This workpJHV11pJHV7*2μ, kanMX, Amp*^*r*^*, PGK1p-*^*Pp*^*MSAS-CYC1t*This workpJHV13pJHV7*2μ, kanMX, Amp*^*r*^*, PGK1p, CYC1t, FBA1p-*^*Acopt*^*patG-ADH1t*This workpJHV17pJHV7*2μ, kanMX, Amp*^*r*^*, PGK1p-*^*Ppvar*^*MSAS-CYC1t*This workpJHV20pRS62H*2μ, hphNT1, Amp*^*r*^*, HXT7p*^*−1-\ −392*^*-*^*An*^*npgA-FBA1t*This workpJHV36pJHV7*2μ, kanMX, Amp*^*r*^*, PGK1p-*^*Ppopt*^*MSAS-CYC1t*This workpJHV49pJHV36*2μ, kanMX, Amp*^*r*^*, PGK1p-*^*Ppopt*^*MSAS-CYC1t, HXT7p*^*−1-\ −392*^*-*^*Anopt*^*npgA-FBA1t*This workpJHV53pJHV13*2μ, kanMX, Amp*^*r*^*, PGK1p-*^*Ppopt*^*MSAS-CYC1t, HXT7p*^*−1-\ −392*^*-*^*Anopt*^*npgA-FBA1t, FBA1p-*^*Acopt*^*patG-ADH1t*This workpRCC-K_URA3--*2μ, kanMX, Amp*^*r*^*, ROX3p-*^*opt*^*Cas9-CYC1t, pSNR5*2-gRNA *for URA3*Mara Reifenrath, University of FrankfurtSiHV33--*ConLS′-gfp-dropout-ConRE′-KanMX-URA 3′Hom-KanR-ColE1-URA3 5′Hom*Simon Harth, University of FrankfurtpRS426CTMSA-PP--*2μ, URA3, Amp*^*r*^*, TEF1p-*^*Ppvar*^*MSAS-CYC1t*Verena Siewers, Chalmers, GothenburgpDKP4832--*2μ, URA3, Amp*^*r*^*, GAL1p-*^*An*^*npgA*Verena Siewers, Chalmers, Gothenburg***S. cerevisiae* strainParent strainRelevant featuresReference**CEN.PK2-1C--*MATa leu2-3112 ura3-52 trp1-289 his3-Δ1 MAL2--8*^*c*^*SUC2*[@bib8]JHY162CEN.PK2--1C*ura3::PGK1p-*^*Ppopt*^*MSAS-CYC1t_HXT7p*^*−1-\ −392*^*-*^*Anopt*^*npgA-FBA1t_FBA1p-*^*Acopt*^*patG-ADH1t*This workJHY163CEN.PK2--1C*ura3::PGK1p-*^*Ppopt*^*MSAS-CYC1t_HXT7p*^*−1-\ −392*^*-*^*Anopt*^*npgA-FBA1t*This work

2.2. Plasmid and strain construction {#sec2.2}
------------------------------------

The DNA sequences of *patG,* ^*Pp*^*MSAS* without the intron ([@bib2]) and *npgA* (respective GeneBank accession numbers JN698985.1, [X55776.1](ncbi-n:X55776.1){#intref0010}, [AF198117.1](ncbi-n:AF198117.1){#intref0015}) were codon-optimized with the JCat tool ([@bib16]). They as well as the native ^*Pp*^*MSAS* gene were ordered from Thermo Fischer Scientific (Germany) as one or more GeneArt Strings DNA fragments. ^*Ppvar*^*MSAS* and native *npgA* were received on the plasmids pRS426CTMSA-PP ([@bib39]) and pDPK4832 ([@bib38]) from Chalmers University of Technology. Codon-optimized sequences were deposited in GenBank under the accession numbers MK791642 (^*Ppopt*^*MSAS*), MK791643 (^*Ppvar*^*MSAS*), MK791644 (^*opt*^*npgA*) and MK791645 (^*opt*^*patG*). For DNA amplification of ^*Ani*^*MSAS* (GeneBank accession number XM_001402371.2) genomic DNA of *A. niger* was donated by Technical University of Munich. Open reading frames, promoters and terminators were amplified by PCR from genomic DNA of CEN.PK2-1C or from plasmids with 35 bp homologous overlaps using primers shown in [supplementary Table S1](#appsec1){ref-type="sec"}. Plasmids were assembled in yeast via homologous recombination of overlapping PCR fragments or String DNA fragments and linearized vector backbone as described previously ([@bib31]). Yeast was transformed with DNA fragments according to [@bib14]. Assembled plasmids were recovered by yeast DNA preparations and were transformed in *E. coli* for propagation and amplification. If only one PCR fragment and a vector backbone were assembled, Gibson assembly was used ([@bib13]). Genomic integrations into the *ura3* locus of CEN.PK2--1C were performed with the CRISPR/Cas9 system described in [@bib11] with the CRISPR/Cas9 plasmid pRCC-K_URA3 from Mara Reifenrath (University of Frankfurt) described in ([@bib30]). The donor DNA for insertion and the up to 500 bp homologous regions upstream and downstream of *ura3* were amplified from plasmid pJHV53 and SIHV33 with the primers listed in [Table S1](#appsec1){ref-type="sec"}. After yeast transformation cells were streaked out on selective YPD medium.

2.3. Cell cultivation {#sec2.3}
---------------------

For fermentations for *m*-cresol and 6-MSA production precultures were cultivated in 150 mL YPD supplemented with corresponding antibiotics in 500 mL Erlenmeyer shake flasks at 180 rpm and 30 °C. Precultures were harvested in exponential phase and for main culture 25 mL YPD with respective antibiotics in 100 mL Erlenmeyer shake flasks were inoculated to an optical density (OD~600\ nm~) of 0.1 in low-OD fermentations and 5 or higher in high-OD fermentations and shaken at 180 rpm 30 °C for 144 h. Cultures for *m*-cresol production were incubated in a 30 °C shaking waterbath (Memmert, Germany) under a hood to avoid *m*-cresol inhalation. Samples for cell density determination and HPLC analysis were taken every 0, 6, 24, 48, 72 (or in some cases 120) and 144 h.

For biotransformation experiments of 6-MSA to *m*-cresol CEN.PK2-1C expressing the codon-optimized *patG* from *A. clavatus* on a plasmid and an empty vector control were grown in YPD medium with corresponding antibiotic at 180 rpm and 30 °C. Twenty-five milliliter YPD with respective antibiotic was supplemented with 3.8 mg 6-MSA in 25 μL ethanol to a final concentration of 1 mM, inoculated with the preculture to an OD~600\ nm~ of 0.1 and shaken at 180 rpm and 30 °C. Optical density, 6-MSA consumption and *m*-cresol production were followed at 0, 3, 6, 24, 48 and 72 h by taking samples of the fermentation.

To determine the toxicity of *m*-cresol a preculture of CEN.PK2-1C was prepared in 150 mL YPD in 500 mL shake flasks at 180 rpm and 30 °C overnight. Fifty milliliter YPD in 300 mL shake flasks were inoculated at an optical density of 0.1, supplemented with different concentrations of *m*-cresol (750, 600, 450, 300, 150 and 0 mg/L) and grown at 180 rpm and 30 °C for 144 h. Cell densities were followed with the Cell Growth Quantifier (Aquila Biolabs GmbH, Germany) ([@bib5]). All experiments were carried out in two biological replicates.

2.4. Growth and metabolite analysis {#sec2.4}
-----------------------------------

For fermentations and biotransformation experiments cell growth was monitored in the spectrophotometer Ultrospec 2100 pro (GE Healthcare, USA) at an optical density of 600 nm. Culture supernatants for HPLC analysis of 6-MSA and *m*-cresol formation were obtained by centrifugation at 10,000 rpm for 2 min, 400 μL were treated with 100 μL acetonitrile, centrifuged again and stored at -20 °C until analysis. Samples were analysed in a HPLC (Dionex) using an Agilent Zorbax SB-C8 column (4.6 × 150 mm, 3.5 μm) at 40 °C. 6-MSA and *m*-cresol were separated by the following gradient of solvent A (0.1% (*v/v*) formic acid in ddH~2~O) and solvent B (0.1% (*v/v*) formic acid in acetonitrile) at a flow rate of 1 mL/min: 5 min 15% B, 20 min linear gradient to 40% B, 1 min linear gradient to 100% B, 4 min 100% B, 1 min linear gradient to 15% B, 4 min 15% B. 6-MSA was detected at 308 nm and *m*-cresol at 270 nm in an UV detector (Dionex UltiMate 3000 Variable Wavelength Detector). For quantification and calibration, 6-MSA/cresol standards were prepared in equal concentrations (*w/v*) in 50% (*v/v*) DMSO/H~2~O from 6-MSA purchased from Cayman Chemical Company (19199) and *m*-cresol purchased from Carl Roth (9269.1). For data analysis and graphing the software Prism 5 (GraphPad, USA) was utilized. Each data point represents the mean of at least two biological replicates and the error bars represent the standard deviation as calculated by the software.

3. Results & discussion {#sec3}
=======================

3.1. Biosynthesis of the precursor 6-methylsalicylic acid {#sec3.1}
---------------------------------------------------------

In order to proof the principle of *de novo m*-cresol production from glucose in *S. cerevisiae*, the precursor 6-MSA is required in sufficient amounts. To produce high levels of 6-MSA, we therefore first expressed and compared native *MSAS* from *A. niger* (^*Ani*^*MSAS*) ([@bib10]) and three MSAS variants from *P. patulum*, namely native (^*Pp*^*MSAS*) ([@bib2]), codon-optimized (^*Ppopt*^*MSAS*) and a variant previously used by [@bib39] (^*Ppvar*^*MSAS*). Compared to native ^*Pp*^*MSAS* this variant exhibits two amino acid exchanges (A699S and N1677S) and 32 silent mutations within its coding region.

[@bib38], [@bib39] and [@bib6] already showed 6-MSA biosynthesis in *S. cerevisiae* in previous work. Similarly, we transformed the *S. cerevisiae* strain CEN.PK2--1C with multi-copy plasmids expressing ^*Ppvar*^*MSAS* ([@bib39]) and native phosphopantetheinyl transferase *npgA* from *A. nidulans* under control of the strong and constitutive promoters *PGK1* and *HXT7*^−1-\ −392^, respectively. Low-OD fermentations of yeast transformants in YPD supplemented with G418 and hygromycin with 20 g/L glucose led to accumulation of up to 115 mg/L 6-MSA in the extracellular medium after 144 h ([Fig. 2](#fig2){ref-type="fig"}). Growth was not affected and was comparable to the strain with empty plasmids which did not produce any 6-MSA (not shown).Fig. 26-MSA formation with strain CEN.PK2--1C carrying the empty vectors pJHV7 and pRS62H as control (green circles), expressing ^*Ppvar*^*MSAS* and native *npgA* from multi-copy plasmids pJHV17 and pJHV20 (red squares) and expressing ^*Ppvar*^*MSAS* and codon-optimized ^*opt*^*npgA* from multi-copy plasmids pJHV17 and pJHV2 (blue triangles). Cultures were inoculated at low OD (0.1) and cultivated for 144 h at 30 °C in 25 mL YPD supplemented with G418 and hygromycin. 6-MSA concentrations were determined in the supernatants. Error bars represent the standard deviation of biological duplicates. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

It has been shown before that codon-optimization of heterologous genes can improve protein expression ([@bib18]) and substrate conversion in *S. cerevisiae* ([@bib41]). However, co-expression of a codon-optimized *npgA (*^*opt*^*npgA*) together with ^*Ppvar*^*MSAS* increased 6-MSA titers only slightly up to 123 mg/L after 144 h. Nevertheless, in all further experiments ^*opt*^*npgA* was used. We also performed similar fermentations in defined SCD medium expressing ^*Ppvar*^*MSAS* from the plasmid pRS426CTMSA-PP and co-expressing ^*opt*^*npgA* but reached only up to 22 mg/L 6-MSA. Interestingly, also [@bib36] observed improved titers of resveratrol production with yeast by using complex medium -- a heterologous pathway which is also dependent on a polyketide synthase-like enzyme. Because of the better results in YPD medium we decided to continue with YPD medium for further experiments.

Compared to the low-OD fermentations, in high-OD fermentations starting with an OD~600~ of 9 the strain expressing ^*Ppvar*^*MSAS* and ^*opt*^*npgA* even reached 6-MSA titers up to 173 mg/L ([Fig. 3](#fig3){ref-type="fig"}).Fig. 36-MSA production by different MSASs in high-OD fermentations. Yeast strain CEN.PK2--1C carrying the empty vectors pJHV7 and pRS62H as control (purple), and strains expressing ^*opt*^*npgA* (pJHV2) and the MSAS variants ^*Ppvar*^*MSAS* (pJHV17; light blue), ^*Ani*^*MSAS* (pJHV5; black), ^*Pp*^*MSAS* (pJHV11; green) or ^*Ppopt*^*MSAS* (pJHV36; orange) from multi-copy plasmids were inoculated at an OD of 9, and cultivated for 144 h at 30 °C in 25 mL YPD supplemented with G418 and hygromycin. 6-MSA concentrations were determined in the supernatants. Error bars represent the standard deviation of biological duplicates. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 3

Next, we tested the native MSASs from *P. patulum* (^Pp^MSAS) ([@bib2]) and from *A. niger* (^Ani^MSAS), also in high-OD fermentations. The ^Ani^MSAS shares less than 50% identity with the ^Pp^MSAS. Compared to ^*Ppvar*^*MSAS*, yeast cells (CEN.PK2--1C) expressing ^*Ani*^*MSAS* (co-expressed with ^*opt*^*npgA*) produced 47% less 6-MSA (91 mg/L) ([Fig. 3](#fig3){ref-type="fig"}). Despite the differences in sequence, the performance of ^Pp^MSAS and ^Ppvar^MSAS did not differ much. Compared to ^Ppvar^MSAS, ^Pp^MSAS produced slightly more 6-MSA (216 mg/L) ([Fig. 3](#fig3){ref-type="fig"}). Finally, a codon-optimized version of ^*Pp*^*MSAS (*^*Ppopt*^*MSAS*) was expressed in CEN.PK2--1C together with ^*opt*^*npgA*. Codon-optimization of ^*Pp*^*MSAS* led to a major increase of 6-MSA titers up to 367 mg/L ([Fig. 3](#fig3){ref-type="fig"}).

With these approaches, we could show that the yeast strain expressing the codon-optimized *MSAS* ^*Ppopt*^*MSAS* from *P. patulum* together with codon-optimized *npgA* from *A. nidulans* was the best 6-MSA producer. Moreover, high-OD fermentations were beneficial for higher levels of 6-MSA. Therefore, these variants and conditions were further used for *de novo m*-cresol biosynthesis in yeast.

3.2. Toxicity of the final product m-cresol {#sec3.2}
-------------------------------------------

As many phenolic compounds display toxic effects on yeast cells already at low concentrations ([@bib1]; [@bib15]) and *m*-cresol has been shown to possess antifungal and antibacterial properties ([@bib22]; [@bib25]), we wanted to evaluate the toxicity of *m*-cresol before studying its biosynthesis from glucose in *S. cerevisiae*. For this purpose we added different concentrations of *m*-cresol to cultures of the wild type strain CEN.PK2--1C and followed growth in YPD medium for 144 h. Already at the lowest tested *m*-cresol concentration of 150 mg/L growth of CEN.PK2--1C was slightly reduced ([Fig. 4](#fig4){ref-type="fig"}). Growth rates were strongly reduced at concentrations of 450--600 mg/L, and growth was completely prevented at 750 mg/L m-cresol (corresponding to 7 mM). Therefore, toxicity is in the same range as that of coniferyl aldehyde, ferulic acid, *p*-coumaric acid and vanillin, reported to impair growth at concentrations of 1.1 mM, 1.8 mM, 9.1 mM and 9.7 mM, respectively ([@bib1]). Additionally, [@bib42] compared the toxicity of furfural, hydroxymethylfurfural, 4-hydroxy-methyl-benzaldehyde, vanillin and guaiacol with that of *m*-cresol. They found that *m*-cresol exhibited the lowest inhibitory effect on yeast growth rate but strongly influenced final cell densities. Altogether, it can be concluded that *m*-cresol exhibits notable toxicity on *S. cerevisiae*.Fig. 4Toxic effects of *m*-cresol on growth of CEN.PK2--1C in YPD supplemented with different *m*-cresol concentrations. Cell densities (starting OD = 0.1) were followed over 144 h with the Cell Growth Quantifier (Aquila Biolabs GmbH) and are depicted as arbitrary units (a.u.). Growth curves represent average of two biological replicates including standard deviations (light grey bars). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 4

3.3. Biotransformation of 6-MSA into m-cresol by 6-MSA decarboxylase {#sec3.3}
--------------------------------------------------------------------

The *in vivo* functionality of the 6-MSA decarboxylase *PatG* from *A. clavatus* ([@bib33]) expressed in yeast was first tested in biotransformation experiments with added 6-MSA. For this, CEN.PK2--1C cells transformed with the codon-optimized *patG (*^*opt*^*patG*) gene expressed under control of the strong *FBA1* promoter from a multi-copy plasmid or an empty vector as control were cultivated in YPD with G418 supplemented with or without 1 mM 6-MSA. In yeast cultures with the empty vector the 6-MSA concentration did not change over 72 h, indicating that 6-MSA cannot normally be converted by yeast cells ([Fig. 5](#fig5){ref-type="fig"}A). The *patG* expressing strain consumed 6-MSA completely within 24 h after an initial 6-h delay, and at the same time 0.67 mM (72 mg/L) of *m*-cresol was found in the extracellular medium ([Fig. 5](#fig5){ref-type="fig"}B). This demonstrates that 6-MSA can be taken up by the yeast cells and is subsequently decarboxylated to *m*-cresol by PatG, confirming the biotransformation experiments of [@bib33] and [@bib23]. However, the product concentration was 30% lower than the utilized substrate concentration, suggesting either slightly limited secretion of *m*-cresol, partial loss by evaporation or further conversion. We investigated the volatility of *m*-cresol at 700 mg/L in YPD medium under fermentation conditions but without yeast cells, and found that less than 5% *m*-cresol had evaporated even after 144 h.Fig. 56-MSA uptake and conversion. A) 6-MSA consumption and B) *m*-cresol production of CEN.PK2--1C expressing 6-MSA decarboxylase ^*opt*^*patG* from multi-copy plasmid pJHV13 or carrying empty vector pJHV7 as reference. Strains were cultivated for 72 h in YPD plus G418 with and without supplementation of 1 mM 6-MSA with an initial OD of 0.2.6-MSA and *m*-cresol concentrations were determined in the supernatants. Error bars represent standard deviation of biological duplicates. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 5

3.4. De novo production of m-cresol from glucose in complex medium {#sec3.4}
------------------------------------------------------------------

The previous experiments demonstrated that the precursor 6-MSA is provided in high amounts when ^*Ppopt*^*MSAS* and ^*opt*^*npgA* are expressed in *S. cerevisiae*. Furthermore, 6-MSA can be transported in both directions across the plasma membrane and should be available for intracellular *m*-cresol production. Additionally, PatG can *in vivo* decarboxylate 6-MSA to *m*-cresol. Now, we expressed ^*Ppopt*^*MSAS*, ^opt^*npgA* and the codon-optimized ^opt^*patG* together under control of the *PGK1*, *HXT7*^−1-\ −392^ and *FBA1* promoters, respectively, from a multi-copy plasmid in CEN.PK2--1C, and performed high-OD fermentations (starting OD~600~ = 5). The yeast cells produced up to 178 mg/L m-cresol from 20 g/L glucose after 144 h in YPD supplemented with G418 ([Fig. 6](#fig6){ref-type="fig"}). Nevertheless, the intermediate 6-MSA was accumulating in the extracellular medium up to 26 mg/L, indicating a bottleneck in the PatG reaction. Final cell densities of the *m*-cresol production strain were slightly lower than those of the strain carrying only an empty vector (OD~600~ of 18 versus 21, respectively), probably reflecting the inhibitory effects of *m*-cresol.Fig. 6Production of the intermediate 6-MSA (orange), final product *m*-cresol (blue) and growth (black) of CEN.PK2--1C expressing ^*Ppopt*^*MSAS,*^*opt*^*npgA* and ^*opt*^*patG* from multi-copy plasmid pJHV53. Fermentations (starting OD = 5) were performed in biological duplicates at 30 °C in YPD supplemented with G418.6-MSA and *m*-cresol concentrations were determined in the supernatants. Error bars represent standard deviation of biological duplicates. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 6

3.5. Genomic integration of the heterologous pathway genes increased 6-MSA and m-cresol production {#sec3.5}
--------------------------------------------------------------------------------------------------

To stabilize expression of pathway genes and prevent plasmid burden and heterogeneity issues by expression from multi-copy plasmids ([@bib21]; [@bib7]; [@bib31]), the heterologous *m*-cresol pathway genes ^*Ppopt*^*MSAS,* ^*opt*^*npgA* and ^*opt*^*patG* under control of the *PGK1*, *HXT7*^−1-\ −392^ and *FBA1* promoters, respectively, were genomically integrated into the *ura3* locus of CEN.PK2--1C. In high-OD fermentations (starting OD = 6), compared to the plasmid-based production strains, genomic integration of ^*Ppopt*^*MSAS* and ^*opt*^*npgA* (without *patG*) led to a 4-fold increase of 6-MSA production up to 1461 mg/L 6-MSA after 144 h in YPD ([Fig. 8](#fig8){ref-type="fig"}A). Additional genomic expression of ^*opt*^*patG* under control of *FBA1* promoter resulted in a 3-fold increase of *m*-cresol production (580 mg/L) ([Fig. 7](#fig7){ref-type="fig"}C), compared to the plasmid-based strain. Compared to the empty vector control strain, both *m*-cresol producing strains reached lower final cell densities reflecting the toxic effects of *m*-cresol ([Fig. 7](#fig7){ref-type="fig"}A). Moreover, the genomic integration nearly completely abolished accumulation of the intermediate 6-MSA ([Fig. 7](#fig7){ref-type="fig"}B), suggesting that the bottleneck in the plasmid-based approach was a plasmid-born or heterogeneity problem or an unbalanced expression ratio between ^*Ppopt*^*MSAS,* ^*opt*^*npgA* and ^*opt*^*patG*.Fig. 7Increase in *m*-cresol production by genomic integration of the pathway genes. Growth (A) and production of 6-MSA (B) and *m*-cresol (C) of CEN.PK2--1C expressing ^*Ppopt*^*MSAS,*^*opt*^*npgA* and ^*opt*^*patG* from multi-copy plasmid pJHV53 (blue) or from genome (strain JHY162; red). As control, the empty vector pRS42K was transformed into CEN.PK2--1C (black). High-OD fermentations (starting OD = 6) were performed in biological duplicates at 30 °C in YPD supplemented with G418 for plasmid maintenance (error bars represent standard deviations). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 7Fig. 8Determination of the limiting factors for 6-MSA and *m*-cresol production. A) 6-MSA titers produced by strain JHY163 (*ura3::*^*Ppopt*^*MSAS-*^*opt*^*npgA*) expressing additionally ^*Ppopt*^*MSAS* and ^*opt*^*npgA* from multi-copy plasmid pJHV49 (pl. M; black) or as control the empty plasmid pRS42K (pl. Empty; light blue). B) *m*-cresol titers produced by strain JHY162 (*ura3::*^*Ppopt*^*MSAS-*^*opt*^*npgA-*^*opt*^*patG*) carrying additionally as a control the empty plasmid pRS42K (pl. Empty; red), or expressing ^*Ppopt*^*MSAS,*^*opt*^*npgA,*^*opt*^*patG* from pJHV53 (pl. M/patG; orange) or ^*opt*^*patG* from pJHV13 (pl. patG; blue) and strain JHY163 (*ura3::*^*Ppopt*^*MSAS-*^*opt*^*npgA*) (g. M) expressing additionally ^*Ppopt*^*MSAS,*^*opt*^*npgA,*^*opt*^*patG* from pJHV53 (pl. M/patG; purple) or ^*opt*^*patG* from pJHV13 (pl. patG; grey). High-OD fermentations (starting OD = 5) were performed in biological duplicates at 30 °C in YPD supplemented with G418 (error bars represent standard deviations). g. M. indicates genomic expression of *MSAS/npgA*, g. M/patG indicates genomic expression of *MSAS/npgA* and patG, + pl. indicates additional overexpression from multi-copy plasmids. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 8

3.6. Evaluating limitations in the heterologous m-cresol pathway {#sec3.6}
----------------------------------------------------------------

Because by expression of the *m*-cresol pathway from a multi-copy plasmid the intermediate 6-MSA was accumulating, the question remained whether expression of the cresol pathway was not balanced or whether a bottleneck in the pathway was limiting *m*-cresol production. To explore this in more detail, in addition to the genomic expression cassette for ^*Ppopt*^*MSAS,* ^*opt*^*npgA* and/or ^*opt*^*patG,* ^*Ppopt*^*MSAS/*^*opt*^*npgA* and/or ^*opt*^*patG* were additionally expressed from a multi-copy plasmid in different combinations.

When in addition to the genomic ^*Ppopt*^*MSAS/*^*opt*^*npgA* copy, ^*Ppopt*^*MSAS/*^*opt*^*npgA* was expressed from a plasmid this led to strong increases in the 6-MSA production rate and final 6-MSA titers (2009 mg/L compared to 1461 mg/L with only the genomic copy and an empty vector as control) ([Fig. 8](#fig8){ref-type="fig"}A), indicating that MSAS activity was limiting 6-MSA production.

The limiting role of ^*Ppopt*^*MSAS/*^*opt*^*npgA* with only the genomic expression copy was also reflected in the *m*-cresol production rates. In all tested combinations, additional overexpresssion of ^*Ppopt*^*MSAS/*^*opt*^*npgA* from a plasmid always strongly increased *m*-cresol production rates, independent of ^*opt*^*patG* copy numbers ([Fig. 8](#fig8){ref-type="fig"}B).

On the other hand, (additional) overexpression of ^*opt*^*patG* from a multi-copy plasmid had no positive effect on the *m*-cresol production rates and did not increase the final *m*-cresol titers. In contrast, surprisingly, overexpression from the multi-copy plasmid without simultaneous overexpression of ^*Ppopt*^*MSAS/*^*opt*^*npgA* or from only the plasmid copy had even a slightly negative effect on *m*-cresol titers (493 mg/L with ^*opt*^*patG* from plasmid additionally to the genomic copy compared to 573 mg/L with only an empty vector, and 440 mg/L or 370 mg/L with ^*opt*^*patG* only from plasmid with or without ^*Ppopt*^*MSAS/*^*opt*^*npgA*). The results indicate that MSAS activity is limiting the *m*-cresol production rate while a balanced expression of *patG* is necessary for optimal *m*-cresol titers. However, it must also be considered that the reached *m*-cresol titers are already very toxic to the cells (compare with [Fig. 4](#fig4){ref-type="fig"}), and this toxicity might limit higher *m*-cresol production titers.

4. Conclusions {#sec4}
==============

This is the first reported *de novo* production of *m*-cresol from glucose in *S. cerevisiae*. By engineering various aspects of the heterologous *m*-cresol pathway, we could progressively increase 6-MSA and *m*-cresol titers. Testing different enzyme variants for the MSAS reaction, changing media and fermentation conditions, and performing biotransformation assays were useful for the establishment of a functional pathway and revealed that genes codon-optimized for *S. cerevisiae* and high-OD fermentations in complex medium were beneficial for high-level production of 6-MSA and *m*-cresol. Another important aspect was the stable integration of the expression cassettes into the genome. Genomic expression of the pathway was clearly superior to expression from multi-copy plasmids. Nevertheless, simultaneous expression of the heterologous genes from genomic cassettes and multi-copy plasmids revealed MSAS activity as a bottleneck in the *m*-cresol formation rate. It remains to be investigated how additional engineering of precursor supply of acetyl-CoA, malonyl-CoA and NADPH ([@bib6]; [@bib20]; [@bib32]; [@bib39]) will further influence *m*-cresol production. Moreover, the clarification of the stimulating effect on 6-MSA production of complex yeast extract-peptone medium compared to synthetic defined medium still needs further investigations. However, toxicity of *m*-cresol will remain the biggest challenge for future optimizations of *m*-cresol production with yeast. To solve this problem, *in situ* product extraction through e.g. biphasic fermentations with dodecane overlay, scale-up and fed-batch bioreactors ([@bib26]) might be promising approaches. Finally, as many *Penicillium* and *Aspergillus* species can natively synthesize *m*-cresol as an intermediate in biosynthesis of the mycotoxin patulin ([@bib29]), it could also be interesting to investigate *m*-cresol production and tolerance with these ascomycetes by e.g. inactivating late stage patulin biosynthesis genes or by heterolous expression of missing genes.
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